Tubomanometry value as an associated factor for medication outcomes in adult acute otitis media with effusion
Adult
Aged, 80 and over
Male
Adolescent
Manometry
Otitis Media with Effusion
Eustachian Tube
Anti-Inflammatory Agents
Histamine Antagonists
Middle Aged
Sensitivity and Specificity
3. Good health
Drug Combinations
03 medical and health sciences
0302 clinical medicine
Acoustic Impedance Tests
ROC Curve
Monoterpenes
Humans
Drug Therapy, Combination
Female
Aged
Retrospective Studies
DOI:
10.1007/s00405-017-4772-8
Publication Date:
2017-10-25T22:56:53Z
AUTHORS (7)
ABSTRACT
Tubomanometry (TMM) is a relatively novel method for testing the eustachian tube (ET) function, which is speculated to be closely related to otitis media with effusion (OME). The purpose of this study is to explore the predictive power of TMM value for medication outcomes in adult acute OME. A cohort of 41 adult acute OME patients with 53 affected ears was studied retrospectively. All these patients completed a 2-week treatment including oral Myrtol Standardized Enteric capsules, nasal steroid, and oral antihistamine. The results showed that the response rate was 41.5% (22/53). The ratio of tympanometry C and TMM value differed significantly between responders and non-responders (P < 0.05), and the TMM value is the only predictive variable for treatment outcomes (P < 0.001, odds ratio 1.873). A ROC analysis of the TMM value for the treatment outcome showed that the area under the curve could achieve 0.773 (P < 0.001), while the optimal cutoff value calculated by Youden index was 1.5, with 72.7% sensitivity and 74.2% specificity. The response rate of ears with 2-6 TMM values could reach 66.7% (16/24), which was significantly higher than that of ears with TMM values 0-1, 20.7% (6/29) (P < 0.001). These findings showed that acute OME patients with a high TMM value and tympanometry C of the affected ear could potentially benefit from medication. The TMM value was an independent predictive factor of the treatment outcomes that could guide treatment decisions.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (15)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....